Noninvasive Evaluation of Ki-67 Overexpression in Breast Cancer Using Ultrasound Radiomics and Habitat Analysis - Top-Institutions - MDSpire

Noninvasive Evaluation of Ki-67 Overexpression in Breast Cancer Using Ultrasound Radiomics and Habitat Analysis

  • By

  • Li Zhu

  • Shanni Dong

  • Xushuang Qin

  • Xiaoying Mi

  • Jiaqi Zhang

  • Xiaoshu Zhu

  • Yuting Liu

  • Jiake Hua

  • Shuangxi Chen

  • April 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Cancer
    • Radiomics
    • Molecular Imaging
    • Oncology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Cancer
    • Radiology
    • Cancer Genomics
    • Machine Learning

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Breast Oncology
    • Radiomics
    • Pathology
    • Bioinformatics

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Radiology
    • Breast Cancer
    • Computational Medicine
    • Oncology

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Breast Imaging
    • Radiomics
    • Oncology
    • Biomedical Informatics

Original Source(s)

Noninvasive Evaluation of Ki-67 Overexpression in Breast Cancer Using Ultrasound Radiomics and Habitat Analysis

  • by Li Zhu, Shanni Dong, Xushuang Qin, Xiaoying Mi, Jiaqi Zhang, Xiaoshu Zhu, Yuting Liu, Jiake Hua, Shuangxi Chen

  • April 29, 2026

Related Content

New Mammography Screening Guidance: Clinical Considerations for Risk-Based Care

New guidance from the American College of Physicians (ACP) recommends biennial mammography screening for average-risk women ages 50 to 74.

  • by

  • May 26, 2026

  • 5 min
Vitamin D-related genetic variants as predictive biomarkers for breast cancer in Jordanian women

MIT president: Why so many optimistic scientists are losing heart